Great Debates and Updates in Hematologic Malignancies 2016

Great Debates and Updates in Hematologic Malignancies is organized by Imedex and would be held during Apr 1 - 2, 2016 at New York Marriott Downtown, New York, New York, USA.

The targeted audience for this medical event basically for hematologists, medical oncologists and other healthcare professionals (physicians, physicians-in-training, oncology nurses, pharmacists, physician assistants, etc.

Conference Objectives are :

* Interpret pertinent clinical trial data for standard of care and novel management strategies and assess how their integration into clinical practice has the potential to enhance outcomes in patients with hematologic malignancies and benign hematologic disorders .
* Assess how molecular and genetic abnormalities can be utilized in diagnosis, prognosis, risk stratification and therapy selection for patients with hematologic malignancies and benign hematologic disorders.
* Evaluate the role of stem cell transplant in the era of novel therapies.
* Evaluate the mechanism of action of standard of care and novel therapeutic agents, and define patient populations who would gain the most clinical benefit from their utilization.
* Formulate evidence-based strategies for the management of hematologic malignancies and benign hematologic disorders that take into consideration patient risk factors, disease stage and prior therapeutic regimens.